Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review of "Fungal Acne".

Journal of drugs in dermatology : JDD·2026

Same author

Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence.

Journal of drugs in dermatology : JDD·2026

Same author

Long-term efficacy and tolerability of clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for acne: pooled results from two 6-month studies.

The Journal of dermatological treatment·2026

Same author

Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age.

Journal of drugs in dermatology : JDD·2025

Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025

Same author

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Dermatology and therapy·2025

Same journal

Severe Nail Psoriasis and Early Psoriatic Arthritis: Illustrative Cases Confirming That Severity of Disease Is Not Solely Dependent on the Extent of Body Surface Area.

The Journal of clinical and aesthetic dermatology·2026

Same journal

Pipeline of Devices and Aesthetics: What Is Left?

The Journal of clinical and aesthetic dermatology·2026

Same journal

An Analysis of Thyrotropin Levels in Patients With Nonscarring Alopecia: A Single-Center Retrospective Comparative Study.

The Journal of clinical and aesthetic dermatology·2026

Same journal

Exploring the Therapeutic Potential of Topical Honey in Atopic Dermatitis.

The Journal of clinical and aesthetic dermatology·2026

Same journal

Plant Exosome Injection: A New Boost for Postlaser Vascular Repair.

The Journal of clinical and aesthetic dermatology·2026

Same journal

The Treatment of Perioral (Periorificial) Dermatitis With Topical Roflumilast 0.3% Cream: An Illustrative Case Study With Rapid Onset and Prolonged Remission.

The Journal of clinical and aesthetic dermatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

A Droplet-Based Microfluidic Approach and Microsphere-PCR Amplification for Single-Stranded DNA Amplicons

A Droplet-Based Microfluidic Approach and Microsphere-PCR Amplification for Single-Stranded DNA Amplicons

Published on: November 14, 2018

Microsphere technology: hype or help?

Leon H Kircik¹

¹Indiana University School of Medicine, Indianapolis, Indiana; Mount Sinai Medical Center, New York, New York; DermResearch, PLLC, Louisville, Kentucky.

The Journal of Clinical and Aesthetic Dermatology

|May 25, 2011

Summary

This summary is machine-generated.

Early topical therapy improves dermatological outcomes. Microsphere technology enhances drug delivery, reducing irritation and boosting patient adherence for better long-term results.

More Related Videos

Lab-on-a-CD Platform for Generating Multicellular Three-dimensional Spheroids

Lab-on-a-CD Platform for Generating Multicellular Three-dimensional Spheroids

Published on: November 7, 2019

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Jun 1, 2026

A Droplet-Based Microfluidic Approach and Microsphere-PCR Amplification for Single-Stranded DNA Amplicons

A Droplet-Based Microfluidic Approach and Microsphere-PCR Amplification for Single-Stranded DNA Amplicons

Published on: November 14, 2018

Lab-on-a-CD Platform for Generating Multicellular Three-dimensional Spheroids

Lab-on-a-CD Platform for Generating Multicellular Three-dimensional Spheroids

Published on: November 7, 2019

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays

Published on: June 23, 2022

Area of Science:

Dermatology
Pharmaceutics
Drug Delivery Systems

Background:

Effective topical therapy initiation is crucial for dermatological disease management and patient experience.
Patient adherence to topical treatments significantly impacts therapeutic outcomes, treatment costs, and patient satisfaction.
Cutaneous irritation from topical formulations, particularly retinoids and benzoyl peroxide, historically challenges treatment initiation and adherence.

Purpose of the Study:

To explore novel formulation approaches for topical dermatological therapies.
To investigate the potential of microsphere technology in improving treatment tolerability and adherence.
To assess the impact of controlled-release formulations on therapeutic outcomes and patient experience.

Main Methods:

Review of current literature on topical drug formulations and delivery systems.
Analysis of microsphere technology's mechanism in controlled drug release.
Evaluation of clinical data on existing microsphere formulations of tretinoin and benzoyl peroxide.

Main Results:

Microsphere technology facilitates controlled release of active ingredients, mitigating rapid high-concentration delivery.
This controlled release is associated with improved treatment outcomes and reduced local cutaneous irritation.
Marketed microsphere formulations of topical tretinoin and benzoyl peroxide show good efficacy and tolerability.

Conclusions:

Novel formulation strategies, such as microsphere technology, can overcome historical challenges of topical therapy irritation.
Improved tolerability and reduced side effects are expected to enhance patient adherence to dermatological treatments.
Microsphere-based topical therapies hold promise for improved long-term therapeutic benefit and patient satisfaction in dermatology.